Abstract
Background Community active case finding for tuberculosis was widely implemented in Europe and North America between 1940-1970, when incidence was comparable to many present-day high-burden countries. Using an interrupted time series analysis, we analysed the effect of the 1957 Glasgow mass chest X-ray campaign to inform contemporary approaches to screening.
Methods and findings Case notifications for 1950-1963 were extracted from public health records and linked to demographic data. We fitted Bayesian multilevel regression models to estimate annual relative case notification rates (CNR) during and after a mass screening intervention implemented over five weeks in 1957 compared to the counterfactual scenario where the intervention had not occurred. We additionally estimated case detection ratios and incidence. From 11/3/1957-12/4/1957, 714,915 people (622,349 of 819,301 [76.0%] resident adults ≥15 years) were screened with miniature chest X-ray; 2,369 (0.4%) were diagnosed with tuberculosis. Pre-intervention (1950-1956), pulmonary CNRs were declining at 2.3% per year from a CNR of 222/100,000 in 1950. With the intervention in 1957, there was a doubling in the pulmonary CNR (RR: 1.95, 95% uncertainty interval [UI]: 1.80-2.11), and 36% decline in the year after (RR: 0.64, 95%UI: 0.59-0.71). Post-intervention (1958-1963) annual rates of decline (5.4% per year) were greater (RR: 0.77, 95%UI: 0.69-0.85), and there were an estimated 4,656 (95%UI: 3,670-5,725) pulmonary case notifications averted due to the intervention. Effects were consistent across all city wards and notifications declined substantially in young children (0-5 years) with the intervention.
Conclusions A single, rapid round of mass screening with chest X-ray (probably the largest ever conducted) resulted in a major and sustained reduction in tuberculosis case notifications. Contemporary high-burden settings may achieve similar benefits with high-intensity screening.
Competing Interest Statement
PM is an PLOS Medicine Academic Editor. All other authors declare no conflicts of interest.
Funding Statement
Yes
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
No ethics approval required.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
Data and code to reproduce analysis are available at https://github.com/petermacp/glasgow-cxr.
